FDA Inspection 1297232 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3014123102

The FDA completed an inspection of Octapharma Plasma Inc on Dec 11, 2025 in Santa Fe Springs, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 11, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santa Fe Springs, CA (United States)

Citations

IDCFRDescription
8021 CFR 606.100(b)(1)Donor criteria

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.